» Articles » PMID: 35661621

Dual Loss of Regulator of G Protein Signaling 2 and 5 Exacerbates Ventricular Myocyte Arrhythmias and Disrupts the Fine-tuning of G Signaling

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Cardiac contractility, essential to maintaining proper cardiac output and circulation, is regulated by G protein-coupled receptor (GPCR) signaling. Previously, the absence of regulator of G protein signaling (RGS) 2 and 5, separately, was shown to cause G protein dysregulation, contributing to modest blood pressure elevation and exaggerated cardiac hypertrophic response to pressure-overload. Whether RGS2 and 5 redundantly control G protein signaling to maintain cardiovascular homeostasis is unknown. Here we examined how the dual absence of RGS2 and 5 (Rgs2/5 dbKO) affects blood pressure and cardiac structure and function.

Methods And Results: We found that Rgs2/5 dbKO mice showed left ventricular dilatation at baseline by echocardiography. Cardiac contractile response to dobutamine stress test was sex-dependently reduced in male Rgs2/5 dbKO relative to WT mice. When subjected to surgery-induced stress, male Rgs2/5 dbKO mice had 75% mortality within 72-96 h after surgery, accompanied by elevated baseline blood pressure and decreased cardiac contractile function. At the cellular level, cardiomyocytes (CM) from Rgs2/5 dbKO mice showed augmented Ca transients and increased incidence of arrhythmia without augmented contractile response to electrical field stimulation (EFS) and activation of β-adrenergic receptors (βAR) with isoproterenol. Dual loss of Rgs2 and 5 suppressed forskolin-induced cAMP production, which was restored by G inactivation with pertussis toxin that also reduced arrhythmogenesis during EFS or βAR stimulation. Cardiomyocyte NCX and PMCA mRNA expression was unaffected in Rgs2/5 dbKO male mice. However, there was an exaggerated elevation of EFS-induced cytoplasmic Ca in the presence of SERCA blockade with thapsigargin.

Conclusions: We conclude that RGS2 and 5 promote normal ventricular rhythm by coordinating their regulatory activity towards G signaling and facilitating cardiomyocyte calcium handling.

Citing Articles

Germline deletion of Rgs2 and/or Rgs5 in male mice does not exacerbate left ventricular remodeling induced by subchronic isoproterenol infusion.

Dahlen S, Mohanty I, Sun B, Nallapaneni S, Osei-Owusu P Physiol Rep. 2025; 13(1):e70178.

PMID: 39746869 PMC: 11695115. DOI: 10.14814/phy2.70178.


Phosphodiesterases Mediate the Augmentation of Myogenic Constriction by Inhibitory G Protein Signaling and is Negatively Modulated by the Dual Action of RGS2 and 5.

Sun B, Smith N, Dixon A, Osei-Owusu P Function (Oxf). 2024; 5(2):zqae003.

PMID: 38486977 PMC: 10935470. DOI: 10.1093/function/zqae003.

References
1.
Cadrin-Tourigny J, Shohoudi A, Roy D, Talajic M, Tadros R, Mondesert B . Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy. JACC Heart Fail. 2017; 5(2):99-106. DOI: 10.1016/j.jchf.2016.10.015. View

2.
Jones D, Tuomi J, Chidiac P . Role of Cholinergic Innervation and RGS2 in Atrial Arrhythmia. Front Physiol. 2012; 3:239. PMC: 3386567. DOI: 10.3389/fphys.2012.00239. View

3.
Pogwizd S, Bers D . Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med. 2004; 14(2):61-6. DOI: 10.1016/j.tcm.2003.12.002. View

4.
Lee K, Lu X, Nguyen C, Feng Q, Chidiac P . Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice. J Mol Cell Cardiol. 2017; 108:194-202. DOI: 10.1016/j.yjmcc.2017.06.007. View

5.
Qin M, Liu X, Liu T, Wang T, Huang C . Potential Role of Regulator of G-Protein Signaling 5 in the Protection of Vagal-Related Bradycardia and Atrial Tachyarrhythmia. J Am Heart Assoc. 2016; 5(3):e002783. PMC: 4943254. DOI: 10.1161/JAHA.115.002783. View